1 completed, 1 recruiting. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Recruiting 1 |
Follow Nephroblastoma: new trials by email Literature Review of Nephroblastoma trials Research Report on Nephroblastoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors Selinexor - Wilms Tumor, Rhabdoid Tumor | Phase 2 | Recruiting | Memorial Sloan Kettering Cancer Center | 45 | 2023-08-01 | 2026-10-23 |
| A Phase II Trial of All-Trans-Retinoic Acid in Combination With Interferon-Alpha 2a in Children With Recurrent Neuroblastoma or Wilms' Tumor IFN-alpha with retinoic acid - Nephroblastoma, Neuroblastoma | Phase 2 | Completed | National Cancer Institute (NCI) | 60 | 1996-07-01 | 2008-03-04 |
Wilms Tumor (2) · Neuroblastoma (1) · Neurofibrosarcoma (1) · Rhabdoid Tumor (1)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Genetic Diseases, Inborn (2) · Kidney Diseases (2) · Kidney Neoplasms (2) · Male Urogenital Diseases (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms by Site (2) · Neoplasms, Complex and Mixed (2) · Neoplasms, Nerve Tissue (2) · Neoplastic Syndromes, Hereditary (2) · Urogenital Diseases (2) · Urogenital Neoplasms (2)
Interferon-alpha (1) · Tretinoin (1) · selinexor (1)
Memorial Sloan Kettering Cancer Center (1) · National Cancer Institute (NCI) (1)
United States (2)